UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 12,128	$ 11,843	$ 11,378
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	610	619	637
Amortization	2,223	2,528	2,719
Provision for (recovery of) losses on accounts receivable	0	(10)	(27)
Loss on disposal of assets	5	1	35
Deferred income taxes	(484)	(901)	(500)
Stock-based compensation expense	92	87	74
(Increase) decrease in accounts receivable	295	137	(365)
(Increase) decrease in income tax and other receivables	897	(91)	(100)
(Increase) decrease in inventories	(360)	422	(141)
(Increase) decrease in prepaid expenses and other current assets	23	28	(19)
Increase (decrease) in accounts payable	286	(265)	188
Increase (decrease) in accrued expenses	(1,187)	(597)	1,508
Net cash provided by operating activities	14,528	13,801	15,387
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures for property and equipment	(3,293)	(176)	(1,110)
Capital expenditures for intangible assets	(9)	(70)	(22)
Net cash provided by (used in) investing activities	(3,302)	(246)	(1,132)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	376	343	491
Common stock purchased and retired	(2,850)	(683)	(1,055)
Payment of taxes for exchange of stock options		(42)
Tax benefit attributable to exercise of stock options	50	114	103
Repayments of notes payable		(4,777)	(4,035)
Dividends paid	(3,916)	(3,846)	(3,765)
Net cash provided by (used in) financing activities	(6,340)	(8,891)	(8,261)
Effect of exchange rate changes on cash	(1,868)	(660)	(1,115)
NET INCREASE IN CASH AND CASH EQUIVALENTS	3,018	4,004	4,879
CASH AT BEGINNING OF YEAR	23,278	19,274	14,395
CASH AT END OF YEAR	26,296	23,278	19,274
Cash paid during the year for income taxes	4,846	5,341	3,094
Cash paid during the year for interest	$ 0	$ 65	$ 296